Related Experiment Video
Updated: Jun 11, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Thrombectomy for patients with a large infarct core: a study-level meta-analysis with trial sequential analysis
Hong-Jie Jhou1,2, Li-Yu Yang2,3, Po-Huang Chen4
1Department of Neurology, Changhua Christian Hospital, Changhua, Taiwan.
Insights
Endovascular thrombectomy significantly improves functional outcomes for stroke patients with large infarct cores but increases the risk of symptomatic intracranial hemorrhage (SICH). Further research is needed to clarify other safety outcomes.
Area of Science:
- Neurology
- Interventional Cardiology
- Public Health
Background:
- Effectiveness and safety of endovascular treatment vs. medical management for large infarct core strokes remain uncertain.
- Large vessel occlusion strokes represent a significant public health challenge requiring optimized treatment strategies.
Purpose of the Study:
- To compare clinical outcomes of mechanical thrombectomy against best medical care in patients with large infarct core strokes.
- To evaluate the efficacy and safety of endovascular thrombectomy in improving functional outcomes and reducing mortality.
Main Methods:
- Systematic review and meta-analysis of six randomized controlled trials.
- Searches conducted in PubMed, Cochrane, and Embase up to November 8, 2023.
- Primary outcome: functional outcomes at 3 months; safety outcomes: mortality, symptomatic intracranial hemorrhage (SICH), decompressive craniectomy.
Main Results:
- Thrombectomy significantly improved neurological prognosis, with increased odds of good (OR 2.90) and favorable (OR 2.40) functional outcomes at 3 months.
- No significant reduction in mortality rates observed with thrombectomy (OR 0.78).
- Increased incidence of SICH in the thrombectomy group (5.5% vs. 3.2%; OR 1.77).
Conclusions:
- High-quality evidence suggests thrombectomy significantly mitigates disability in large infarction patients.
- Thrombectomy increases the risk of symptomatic intracranial hemorrhage.
- Trial sequential analysis confirmed favorable functional outcomes but yielded inconclusive results for other safety endpoints.
Background:
The effectiveness and safety of endovascular treatment compared with medical management alone regarding outcomes for patients with a large infarct core remain uncertain.
Objectives:
To juxtapose the clinical outcomes of thrombectomy versus the best medical care in patients with a large infarct core.
Design:
Systematic review and meta-analysis.
Data Sources And Methods:
We conducted searches in PubMed, Cochrane, and Embase for articles published up until November 8, 2023. Randomized trials were selected for inclusion if they encompassed patients with large vessel occlusion and sizable strokes receiving thrombectomy. The primary outcome was functional outcomes at 3 months after pooling data using random-effects modeling. Safety outcomes included mortality at 3 months, symptomatic intracranial hemorrhage (SICH), and decompressive craniectomy. We performed a trial sequential analysis to balance type I and II errors.
Results:
From 904 citations, we identified six randomized trials, involving a cohort of 1897 patients with a large ischemic region. Of these, 953 individuals underwent endovascular thrombectomy. At 3 months, thrombectomy was significantly correlated with better neurological prognosis, as evidenced by the increased odds of good functional outcomes (odds ratio (OR), 2.90; 95% confidence interval (CI), 2.08-4.05) and favorable functional outcomes (OR, 2.40; 95% CI, 1.86-3.09). Mortality rates did not demonstrably diminish as a consequence of the endovascular management (OR, 0.78; 95% CI, 0.58-1.06). However, the incidence of SICH was greater in the thrombectomy group compared to those with only medical treatment (5.5% vs 3.2%; OR, 1.77; 95% CI, 1.11-2.83). The application of trial sequential analysis yielded definitive evidence regarding favorable function outcomes and a shift in the distribution of modified Rankin scale scores at 3 months; however, others remained inconclusive.
Conclusion:
The results from most of the included trials display consistency. Meta-analysis of these six randomized trials offers high-quality evidence that thrombectomy significantly mitigates disability in patients with a large infarction, while also increasing the risk of SICH.
Trial Registration:
PROSPERO, CRD42023480359.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations

